On April 19, 2020, President Trump issued an Executive Order (E.O.) on “National Emergency Authority to Temporarily Extend Deadlines for Certain Estimated Payments” directing the Secretary of the Treasury, in consultation...more
On March 20, 2020, the Office of the United States Trade Representative (USTR) announced that it was opening a docket to consider additional modifications to tariffs being imposed on China-origin medical-care products...more
After more than a year of sometimes contentious negotiations, the United States, Mexico, and Canada (the “Parties”) reached an agreement late Sunday night to revise the North American Free Trade Agreement (“NAFTA”)—renaming...more
10/8/2018
/ Agricultural Sector ,
Automotive Industry ,
Biologics ,
Canada ,
Cross-Border Transactions ,
Currency Manipulation ,
Exports ,
Free Trade Agreements ,
Imports ,
Intellectual Property Protection ,
Investor State Dispute Settlement (ISDS) ,
Mexico ,
NAFTA ,
Procurement Guidelines ,
Sunset Provisions ,
Tariffs ,
Trade Relations ,
Trans-Pacific Partnership ,
Trump Administration ,
United States-Mexico-Canada Agreement (USMCA)
On September 17, President Trump announced the imposition of a 10% ad valorem duty on approximately $200 billion worth of Chinese imports, pursuant to Section 301 of the Trade Act of 1974. The Office of the U.S. Trade...more
On July 10, the Office of the United States Trade Representative (USTR) released a list of Chinese products that may become subject to an additional duty of 10% ad valorem, pursuant to Section 301 of the Trade Act of 1974....more